Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1997-10-01
1999-08-17
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
A01N 4500
Patent
active
059394072
ABSTRACT:
The present invention pertains to a method of protecting against neuron loss in a subject by administering a compound that protects against neuron loss by acting through a vitamin D receptor. Some of these compounds may prevent or retard neuron loss by regulating intraneuronal and/or peripheral calcium and phosphate levels. Other compounds of the invention act through a vitamin D receptor to protect against neuron loss through mechanisms not involving calcium or phosphate regulation. A preferred compound is a biologically active form of vitamin D, a precursor, metabolite, or analog of vitamin D. A preferred form of vitamin D is calcitriol. In another embodiment, the compound is a compound that acts by modulating the biological activity of vitamin D, a precursor, metabolite, or analog of vitamin D. For example, the compound may modulate the biological activity of the vitamin D compound by regulating the amount of the vitamin D compound which is available to protect against neuron loss or it may act by altering the ability of the vitamin D compound to protect against neuron loss. In an alternative embodiment, the compound is a compound that protects against neuron loss through a mechanism similar to that of the vitamin D compound but not involving a vitamin D receptor. The compound is administered to a subject in an amount and over a period of time effective to protect against neuron loss.
REFERENCES:
patent: 4897388 (1990-01-01), Malluche
patent: 4957909 (1990-09-01), Abou-Gharbia et al.
patent: 5089517 (1992-02-01), Choi et al.
patent: 5153196 (1992-10-01), McQuaid et al.
patent: 5168103 (1992-12-01), Kinney et al.
patent: 5179109 (1993-01-01), Kamenka et al.
patent: 5196421 (1993-03-01), McQuaid et al.
Sprott, R.L. (1991) "Development of Animal Models of Aging at the National Institute on Aging" Neurobiology of Aging 12(6):635-638.
Flood, D.G. and Coleman, P.D. (1988) "Neuron Numbers and Sizes in Aging Brain: Comparisons of Human, Monkey, and Rodent Data" Neurobiology of Aging 9(5/6):453-463.
Kung Sutherland, M. et al. (1992) "Reduction of Vitamin D Hormone Receptor mRNA Levels in Alzheimer As Compared to Huntington Hippocampus: Correlation With Calbindin-28k mRNA Levels" Molecular Brain Research 13: 239-250.
Musiol, I.M. et al. (1993) "Vitamin D Nuclear Binding to Neurons of the Alzheimer Pathogenic Region of Nucelus Basalis of Meynert, Central Amygdaloid Group and Nucleus of Diagonal Band of Broca" Chemical Abstracts 118(25): Abstract No. 252564.
Musiol, I.M. et al. (1992) "Vitamin D Nuclear Binding to Neurons of the Septal, Substritial and Amygdaloid Area in the Siberian Hamster (Phodopus Sungorus) Brain" Neuroscience 48(4):841-848.
Saporito, M.S. et al. (1993) "Pharmacological Induction of Nerve Growth Factor mRNA in Adult Rat Brain" Experimental Neurology 123(2): 295-302.
Stumpf, W.E. et al. (1982) "Brain Target Sites for 1,25-Dihydroxyvitamin D3" Science 215(4538): 1403-1405.
Landfield, P.W. et al. (1992) "Mechanisms of Neuronal Death in Brain Aging and Alzheimer's Disease: Role of Endocrine-Mediated Calcium Dyshomeostasis" J. Neurobiol. 23(9):1247-1260.
Landfield, P.W. et al. (1991) "Phosphate/Calcium Aterations in the First Stages of Alzheimer's Disease: Implications for Etiology and Pathogenesis" J. Neurol. Sci. 106:221-229.
Ferrier, I.N. et al. (1990) "Reduced Gastrointestinal Absorption of Calcium in Dementia" Age Ageing 19:368-375.
Ogihara, T. et al. (1990) "Possible Participation of Calcium-Regulating Factors in Senile Dementia in Elderly Female Subjects" Gerontology 36(Supp. 1):25-30.
Kachaturian, Z.S. (1989) "The Role of Calcium Regulation in Brain Aging: Reexamination of a Hypothesis" Aging 1:17-34.
Martyn, C.N. et al. (1989) "Calcium Metabolism in Alzheimer's Disease: A Case-Control Study" Gerontology 35:153-157.
Gibson, G.E. and Peterson, C. (1987) "Calcium and the Aging Nervous System" Neurobiol. Aging 8:329-344.
Orwoll, E.S. and Meier, D.E. (1986) "Alterations In Calcium Vitamin D, and Parathyroid Hormone Physiology In Normal Men With Aging: Relationship to the Development of Senile Osteopenia" J. Clin. Endocrinol. Metab. 63:1262-1269.
Kachaturian, Z.S. (1984) "Towards Theories of Brain Aging" Handbook of Studies on Psychiatry and Old Age (In: D.S. Kay and G.W. Burrows, eds.) 7-30.
Landfield, P.W. et al. (1981) "Brain Aging Correlates: Retardation by Hormonal Pharmacological Treatments" Science 214:581-584.
Landfield, P.W. et al. (1978) "Hippocampal Aging and Adrenocorticoids: Quantitative Correlations" Science 202:1098-1102.
Hardman, J.G. and Lumburd, L.E. (1996); "Goodman & Gilman: The Pharmacological Basis of Therapeutics," (9th ed., McGraw Hill, NY) 1529-1536.
Katzman, R. and Saitoh, T (1991); "Advances in Alzheimer's Disease," The FASB Journal 5:278-286.
Cohen, G.D.(1983); "Alzheimer's Disease--The Human Concept," Banbury Report 15; Biological Aspects of Alzheimer's Disease 3-6.
Cintins Marianne M.
Jones Dwayne C.
University of Kentucky Research Foundation
LandOfFree
Method of protecting against neuron loss does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of protecting against neuron loss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of protecting against neuron loss will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314917